Discontinuation report THALOMID

Last updated on 2024-04-01 History
Report ID 205531
Drug Identification Number 02355221
Brand name THALOMID
Common or Proper name THALOMID
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status CANCELLED POST MARKET
Active Ingredient(s) THALIDOMIDE
Strength(s) 200MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 2BLPx14
ATC code L04AX
ATC description IMMUNOSUPPRESSANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2024-03-31
Actual discontinuation date 2024-03-31
Remaining supply date 2024-03-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
ST-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2024-04-01 English Compare
v4 2023-09-29 French Compare
v3 2023-09-29 English Compare
v2 2023-09-29 French Compare
v1 2023-09-29 English Compare

Showing 1 to 5 of 5